August 14, 2003Open Access

The burdens of cancer therapy

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Mucositis was clinically and economically significant among patients with solid tumors who were receiving myelosuppressive chemotherapy. New preventive and therapeutic agents are needed.

Leer artículo completoexternamente

Me gusta

Guardar

Ver artículo completo

Cite This Study

Elting et al. (Thu,) studied this question.

synapsesocial.com/papers/69d57425def4cefba5c22a76 https://doi.org/https://doi.org/10.1002/cncr.11671

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Clinical impact of chemotherapy dose escalation in patients with hematologic malignancies and solid tumors.1997 · 110 citations
2The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies.1998 · 210 citations
3Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide1960 · 1,040 citations
4Toxicity in head and neck cancer: a review of trends and issues2000 · 356 citations
5Oral mucositis in myelosuppressive cancer therapy1999 · 87 citations

Me gusta

Guardar

Ver artículo completo